首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Reduced release of DNA from streptococcus pneumoniae after treatment with rifampin in comparison to spontaneous growth and ceftriaxone treatment.
【24h】

Reduced release of DNA from streptococcus pneumoniae after treatment with rifampin in comparison to spontaneous growth and ceftriaxone treatment.

机译:与自发生长和头孢曲松治疗相比,利福平治疗后从肺炎链球菌释放的DNA减少。

获取原文
获取原文并翻译 | 示例
           

摘要

In order to study the release of DNA from Streptococcus pneumoniae in vitro during spontaneous growth and treatment with ceftriaxone or rifampin, a semiquantitative polymerase chain reaction was used. During spontaneous growth, high concentrations of bacterial DNA were released. Exposure to 10 microg/ml of ceftriaxone decreased the DNA release, in median, by 19 times (P=0.03 vs. spontaneous growth). Treatment with 10 microg/ml of rifampin led to a reduction of DNA release, in median, by a factor of 49 (P=0.03 vs. ceftriaxone; six experiments performed on different days).
机译:为了研究自发生长和头孢曲松或利福平处理过程中肺炎链球菌DNA的体外释放,使用了半定量聚合酶链反应。在自发生长期间,释放出高浓度的细菌DNA。暴露于10微克/毫升的头孢曲松钠可使DNA释放中值降低19倍(相对于自发生长,P = 0.03)。用10微克/毫升的利福平处理导致DNA释放的中位数降低了49倍(相对于头孢曲松,P = 0.03;在不同的日子进行了6次实验)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号